Retina/Vitreous

Top Story

Phase 1 study of THR-687 for DME shows improvement in vision

February 13, 2020
Grand Rounds at the New England Eye Center

Young woman presents with unilateral eye discomfort

Ocular Surgery News U.S. Edition, February 25, 2020
Christine L. Benador-Shen, MD; Geetha Athappilly, MD; Thomas R. Hedges III, MD
A 24-year-old African American woman with a medical history of right-sided Bell’s palsy, hidradenitis suppurativa and borderline hypertension was referred to the…
Point/Counter

What circumstances would make brolucizumab your anti-VEGF drug of choice?

Ocular Surgery News U.S. Edition, February 25, 2020
Exudative age-related macular degeneration is the leading cause of blindness in the developed world in people older than 65 years of age. Numerous intravitreal anti-VEGF…
Cover Story

Successful retinal injection practice depends on clinical efficiency, patient satisfaction

Ocular Surgery News U.S. Edition, February 25, 2020
Anti-VEGF injections can help maintain and sometimes improve visual acuity in patients with degenerative retinal diseases, but there is an associated high treatment…
More Headlines »
Case Report

Lamellar Macular Hole Formation in a Patient With Diabetic CME Treated by Intravitreal Bevacizumab Injections

Ophthalmic Surgery, Lasers and Imaging Retina, Volume 4
Online Only, July 1, 2012
A 49-year-old woman with a diagnosis of diabetic cystoid macular edema in both eyes presented with the appearance of a…
More »
CME

Drug Delivery in Neovascular Retinal Disease

This activity is supported by an educational grant from Genentech, Inc.

More »
Video
Meeting News

VIDEO: Surgeon offers pearls to achieve best outcomes in retinal detachment surgery

January 31, 2020
More »
Meeting News

Phase 1 study of THR-687 for DME shows improvement in vision

February 13, 2020
An open-label, multicenter, single dose escalation study evaluating the safety of a single intravitreal injection of three increasing doses of…

Grand Rounds at the New England Eye Center

Young woman presents with unilateral eye discomfort

Ocular Surgery News U.S. Edition, February 25, 2020
Christine L. Benador-Shen, MD; Geetha Athappilly, MD; Thomas R. Hedges III, MD
A 24-year-old African American woman with a medical history of right-sided Bell’s palsy, hidradenitis suppurativa and borderline hypertension…

Point/Counter

What circumstances would make brolucizumab your anti-VEGF drug of choice?

Ocular Surgery News U.S. Edition, February 25, 2020
Exudative age-related macular degeneration is the leading cause of blindness in the developed world in people older than 65 years of age. Numerous…

Cover Story

Successful retinal injection practice depends on clinical efficiency, patient satisfaction

Ocular Surgery News U.S. Edition, February 25, 2020
Anti-VEGF injections can help maintain and sometimes improve visual acuity in patients with degenerative retinal diseases, but there is an associated…

Grading of DR by first-line caregivers needs improvement

Ocular Surgery News U.S. Edition, February 25, 2020
The majority of optometrists perform a dilated fundus examination to screen for diabetic retinopathy, but the concordance between the examination and…

Lindstrom's Perspective

Advances needed to alleviate burden of retinal disease treatment

Ocular Surgery News U.S. Edition, February 25, 2020
Richard L. Lindstrom, MD
We now have our fourth anti-VEGF drug, Beovu from Novartis. Each of the available drugs — Avastin, Lucentis, Eylea and Beovu — typically…

Meeting News

Eylea reduced risk for vision-threatening complications at 2 years

February 12, 2020
The 2-year results of the phase 3 PANORAMA trial evaluating intervention with aflibercept for patients with moderately severe to severe…

Meeting News

Diabetic retinopathy confers stroke risk in diabetes

February 12, 2020
Among patients with diabetes, those with diabetic retinopathy had elevated stroke risk compared with those who did not, according to new data from…

Blog

BLOG: Angiogenesis 2020: Noteworthy and notable presentations

February 11, 2020
The Bascom Palmer Angiogenesis meeting took place on Feb. 8, covering disease pathogenesis and emerging treatment options for various retinal…

Positive results seen in fourth cohort of OpRegen phase 1/2a study

February 10, 2020
Based on positive early data available for the first five patients in a phase 1/2a clinical study of OpRegen, Lineage Cell Therapeutics announced it…

Meeting NewsVideo

VIDEO: Expert discusses prognostic factors of retinal detachment surgery

February 6, 2020
TREVISO, Italy — At the Retina 2020: New Trends meeting, Francesco Boscia, MD, speaks about the prognostic factors for macula-off retinal…

Meeting NewsVideo

VIDEO: Treating floaters with laser procedures

February 5, 2020
KOLOA, Hawaii — At Hawaiian Eye 2020, Christopher Wood, MD, discusses his experience using lasers to treat floaters. “I think it’s…

Meeting News

Management of diabetes-related eye disease moves toward flexible, personalized approaches

February 4, 2020
TREVISO, Italy — Management of diabetic retinopathy requires flexible, personalized approaches, which new advances are making possible. …

EyePoint, Equinox enter licensing agreement for vorolanib

February 4, 2020
EyePoint Pharmaceuticals and Equinox Science have signed an exclusive license agreement for the development of vorolanib, according to a press…

Meeting NewsVideo

VIDEO: Pneumatic retinopexy yields better visual outcomes than vitrectomy for retinal detachment

February 3, 2020
TREVISO, Italy — A prospective, randomized study carried out at St. Michael’s Hospital in Toronto showed superior results for pneumatic…

Meeting NewsVideo

VIDEO: Combination of anti-VEGF, laser may be used for proliferative diabetic retinopathy

February 3, 2020
TREVISO, Italy — At the Retina 2020: New Trends meeting, Francesco Bandello, MD, speaks about the treatment of proliferative diabetic…

Meeting NewsVideo

VIDEO: Proper tracking, surgical procedure essential to reduce endophthalmitis risk

February 2, 2020
KOLOA, Hawaii — At Hawaiian Eye 2020, Randall J. Olson, MD, CEO of Moran Eye Center, addresses core principles he discussed in his…

FDA grants rare pediatric disease designation for QR-421a in retinitis pigmentosa

January 31, 2020
QR-421a has received rare pediatric disease designation from the FDA for the treatment of retinitis pigmentosa, according to a press release from…

Meeting NewsVideo

VIDEO: Surgeon offers pearls to achieve best outcomes in retinal detachment surgery

January 31, 2020
TREVISO, Italy — At the Retina 2020: New Trends meeting, Giuseppe Scarpa, MD, speaks about new techniques and technologies that improve the…

Meeting NewsVideo

VIDEO: Adaptive optics in retinal imaging a revolutionary step forward

January 30, 2020
TREVISO, Italy — Adaptive optics provide high-resolution imaging and visualization of microstructures of the retina to the level of…

More Headlines »